SCHEMBL23218003

SCHEMBL23218003

Cc1cccc(-c2nn(C(=O)OC(C)(C)C)cc2-c2ccc3ncc(OCCCCNC(=O)OCc4ccccc4)cc3c2)n1

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 13/20 0.42
SUCNR1 Q9BXA5 4/20 0.39
BRD4 O60885 2/20 0.38
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24312358 0.78 TGFBR1 (0.48) TGFBR1
SCHEMBL24312439 0.71 HTT (0.47) BRD4MAPT
SCHEMBL23217933 0.68 TGFBR1 (0.54) TGFBR1
SCHEMBL24311930 0.67 L3MBTL1 (0.43) BRD4MAPT
SCHEMBL24312357 0.66 TGFBR1 (0.53) TGFBR1
SCHEMBL2572901 0.65 SUCNR1 (0.49) SUCNR1MAPT
SCHEMBL31457839 0.65 MAPT (0.51) SUCNR1MAPT
SCHEMBL13480435 0.64 MAPT (0.65) MAPT
SCHEMBL23217905 0.63 CA12 (0.40) SUCNR1
SCHEMBL10115818 0.63 MAPT (0.55) SUCNR1BRD4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076905-A1 ALK5 INHIBITORS, CONJUGATES, AND USES THEREOF SILVERBACK THERAPEUTICS, INC. (US) 2022-04-14 WO disclosed
WO-2021072330-A1 GALNAC-TGFBR1 INHIBITOR CONJUGATES FOR THE TREATMENT OF LIVER DISEASES SILVERBACK THERAPEUTICS, INC. (US) 2021-04-15 WO disclosed